Investing.com - Theravance Biopharma (NASDAQ:TBPH) reported on Monday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Theravance Biopharma announced earnings per share of $12.14 on revenue of $12.45M. Analysts polled by Investing.com anticipated EPS of $-0.05 on revenue of $11.45M.
Theravance Biopharma shares are up 19.33% from the beginning of the year, still down 23.69% from its 52 week high of $13.17 set on January 10.
Theravance Biopharma follows other major Healthcare sector earnings this month
Theravance Biopharma's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar